Transurethrale Injektionen mit Bulkamid

Zusammenfassung

Das Bulkamid-Bulking-Verfahren ist gering invasiv und bietet sich als Alternative zur Behandlung der Belastungsinkontinenz unter anderem für Patientinnen mit Adipositas, Komorbiditäten und Rezidiven nach anderen Eingriffen an. Am DRK Krankenhaus Chemnitz-Rabenstein haben wir seit Oktober 2005 247 Patientinnen mit Bulkamid behandelt. Die Erfolgsrate liegt bei 67,9 % und 47,5 % der Patientinnen sind objektiv geheilt, was insbesondere in Anbetracht der Negativauswahl der Patientinnen in Bezug auf Alter, BMI, Komorbidität und Rezidiven nach anderen Verfahren ein positives Ergebnis ist. 80,1 % der Patientinnen sind mit dem Resultat zufrieden und die Erfolgsrate ist zwischen 6 und 30 Monaten nach dem Eingriff unverändert. Das Material bietet gute Eigenschaften. Die Vorteile der Injektionsbehandlung liegen in der einfachen Durchführbarkeit und niedrigen Komplikationsrate. Der Eingriff ist von den Patientinnen gut akzeptiert und aus Anwendersicht leicht erlernbar. Zur endgültigen Bewertung sind jedoch weitere Daten erforderlich.

Abstract

Due to its minimally invasive character, Bulkamid bulking may be an alternative procedure for the treatment of female urinary stress incontinence in patients with adipositas, comorbidities or relapse after other treatments. At the DRK Clinic Chemnitz-Rabenstein we have treated 247 women with Bulkamid since October 2005. The success rate was 67.9 % with 47.5 % of the patients objectively cured. This constitutes a positive result, particularly when considering the problematic selection criteria such as age, BMI, comorbidities and relapse following other treatments. 80.1 % of the patients are happy with the result and there was no notable change in the post treatment success rate at 6 and 30 months. The material has good properties, with ease of use, visual control and low complication rates constituting the key advantages of this approach. It is well accepted by patients and easy for the operating surgeon to learn, although more data are needed for a final evaluation.

Schlüsselwörter

Belastungsinkontinenz - Bulkamid - Bulking - Hydrogel - minimalinvasiv

Key words

urinary stress incontinece - Bulkamid - bulking - hydrogel - minimally invasive

Literatur

• 1 Beutel M E, Hessel A, Schwarz R et al. Prevalence of urinary incontinence in the German population. Prävalenz der Urininkontinenz in der deutschen Bevölkerung. Komorbidität, Lebensqualität, Einflussgrössen.  Der Urologe [A]. 2005;  44 232-238
• 2 Welz-Barth A, Füsgen I, Melchior H J. 1999 rerun of the 1996 German Urinary Incontinence Survey: Will doctors ever ask?.  World J Urol. 2000;  18 436-438
• 3 Distler W. Harninkontinenz – Tabuthema in der Postmenopause.  Zae FQ. 2000;  94 211-215
• 4 Papanicolaou S, Pons M E, Hampel C et al. Medical resource utilisation and cost of care for women seeking treatment for urinary incontinence in an outpatient setting. Examples from three countries participating in the PURE study.  Maturitas. 2005;  52 (Suppl. 2) S35-S47
• 5 Stamey T A. Endoscopic suspension of the vesical neck for surgically curable urinary incontinence in the female.  Monogr Urol. 1981;  2 65
• 6 Klarskov N, Lose G. Urethral injection therapy: what is the mechanism of action?.  Neurourol Urodyn. 2008;  27 789-792
• 7 Klarskov N, Lose G. Urethral pressure reflectometry and pressure profilometry in healthy volunteers and stress urinary incontinent women.  Neurourol Urodyn. 2008;  27 807-812
• 8 Sander P, Lose G. Surgical options in the treatment of stress urinary incontinence in women (Review).  Minerva Ginecol. 2007;  59 619-627
• 9 Klarskov N, Lose G. Urethral pressure reflectometry vs. urethral pressure profilometry in women: a comparative study of reproducibility and accuracy.  BJU Int. 2007;  100 351-356
• 10 Lose G, Mouritsen L, Nielsen J B. A new bulking agent (polyacrylamide hydrogel) for treating stress urinary incontinence in women.  BJU Int. 2006;  98 100-104
• 11 Hunskaar S, Lose G, Sykes D et al. The prevalence of urinary incontinence in women in four European countries.  BJU Int. 2004;  93 324-330
• 12 Sørensen C, Sander P, Lose G. Experiences with bulkamid at Glostrup-Hospital.  Int Urogynecol J. 2007;  18 (Suppl. 1) S190-S191
• 13 Appell R A, Dmochowski R R, Herschorn S. Urethral injections for female stress incontinence.  BJU Int. 2006;  98 (Suppl. 1) 27-30
• 14 Balmforth J, Cardozo L D. Trends toward less invasive treatment of female stress urinary incontinence.  Urology. 2003;  62 52-60
• 15 Cody J, Wyness L, Wallace S et al. Systematic review of the clinical effectiveness and cost-effectiveness of tension-free vaginal tape for treatment of urinary stress incontinence.  Health Technol Assess. 2003;  7 22
• 16 Iselin C E, Webster G D. Office management of female urinary incontinence.  Urogynecol. 1998;  25 625
• 17 Keegan P E, Atiemo K, Cody J et al. Periurethral injection therapy for urinary incontinence in women.  Cochrane Database Syst Rev. 2007; 
• 18 Lightner D J. Review of the available urethral bulking agents.  Curr Opin Urol. 2002;  12 333-338
• 19 Lightner D J, Itano N B, Sweat S D et al. Injectable agents: present and future.  Curr Urol Rep. 2002;  3 408-413
• 20 Pannek J, Brands F H, Senge T. Particle migration after transurethral injection of carbon coated beads for stress urinary incontinence.  J Urol. 2001;  166 1350-1353
• 21 Perimenis P, Giannitsas K. Injectables for the treatment of stress urinary incontinence: current use and future perspectives.  Expert Opin Pharmacother. 2006;  7 1441-1447
• 22 Starkman J S, Scarpero H, Dmochowski R R. Emerging periurethral bulking agents for female stress urinary incontinence: is new necessarily better?.  Curr Urol Rep. 2006;  7 405-413
• 23 Su T H, Hsu C Y, Chen J C. Injection therapy for stress incontinence in women.  Int Urogynecol J Pelvic Floor Dysfunct. 1999;  10 200-206
• 24 Sweat S D, Lightner D J. Complications of sterile abscess formation and pulmonary embolism following periurethral bulking agents.  J Urol. 1999;  161 93-96
• 25 Kerr L A. Bulking agents in the treatment of stress urinary incontinence: history, outcomes, patient populations and reimbursement profile.  Rev Urol. 2005;  7 (Suppl. 1) S3-S11
• 26 Smith E A, Oehme F W. Acrylamide and polyacrylamide: a review of production, use, environmental fate and neurotoxocity.  Rev Environ Health. 1991;  9 215-228
• 27 King D J, Noss R R. Toxicity of polyacrylamide and acrylamide monomer.  Rev Environ Health. 1989;  8 3-16
• 28 Guaraldi G, Orlando G, De Fazio D et al. Comparison of three different interventions for the correction of HIV-associated facial lipoatrophy: a prospective study.  Antiviral Ther. 2005;  10 753-759
• 29 Lose G, Mouritsen L, Nielsen J B. A new bulking agent (polyacrylamide hydrogel) for treating stress urinary incontinence in women.  BJU Int. 2006;  98 100-117
• 30 Bello G, Jackson I T, Keskin M, Kelly C et al. The use of polyacrylamide gel in soft-tissue augmentation: an experimental assessment.  Plast Reconstr Surg. 2007;  119 1326-1336
• 31 Lightner D J. Review of the available urethral bulking agents.  Curr Opin Urol. 2002;  12 333-338
• 32 Schultz J A, Nager C W, Stanton S L, Baessler K. Bulking agents for stress urinary incontinence: short-term results and complications in a randomized comparison of periurethral and transurethral injections.  Int Urogynecol J Pelvis Floor Dysfunct. 2004;  15 261-265
• 33 Qiao Q, Wang X, Sun J, Zhao R et al. Management for postoperative complications of breast augmentation by injected poly-acrylamide hydrogel.  Aesth Plast Surg. 2005;  29 156-161
• 34 Cheng N, Xu S, Deng H et al. Migration of implants: a problem with injectable polyacrylamide gel in aesthetic plastic surgery.  Aesth Plast Surg. 2006;  30 215-225
• 35 von Buelow S, von Heimburg D, Pallua N. Efficacy and safety of polyacrylamide hydrogel for facial soft-tissue augmentation.  Plast Reconstr Surg. 2005;  116 1137-1146 discussion 1147-1148
• 36 von Buelow S, Pallua N. Efficacy and safety of polyacrylamide hydrogel for facial soft-tissue augmentation in a 2-year follow-up: a prospective multicenter study for evaluation of safety and aesthetic results in 101 patients.  Plast Reconstr Surg. 2006;  118 (Suppl. 3) 85S-91S
• 37 Lise H C. Tissue integration of polyacrylamide hydrogel: an experimental study of periurethral, perivesical, and mammary gland tissue in the pig.  Dermatol Surg. 2008;  34 S68-S77
• 38 Appel R, Dmochowski R, Herschorn S. Optimum attributes for ideal bulking agent.  BJU International. 2006;  98 (Suppl. 1) 27-30